Vgxi selects cryoport for biostorage, bioservices and supply chain solutions to advance next-generation therapies

Partnership will enhance support for biopharmaceutical companies in developing cell and gene therapies and mrna-based treatments nashville, tenn. and conroe, texas , oct. 15, 2024 /prnewswire/ -- cryoport, inc. (nasdaq: cyrx) ("cryoport"), a global leader in supply chain solutions for the life sciences, and vgxi, inc., (vxgi) a subsidiary of geneone life science inc. ("geneone" kospi: 011000) today announced a strategic partnership to support biopharmaceutical companies in developing cell and gene therapies and mrna-based treatments.
CYRX Ratings Summary
CYRX Quant Ranking